Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...

The American College of Obstetricians and Gynecologists (ACOG) plans to develop and release recommendations on maternal ...

More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization and UNICEF.

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...

While your baby may not have made his big entrance yet, it's important to understand the recommended vaccines and schedule now. That's because your child’s immunizations will play a major role during ...

FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.

The diagnosis was confirmed through rapid testing after the Coconino County resident was admitted to Flagstaff Medical Center. Pneumonic plague is the only form of the plague that can be transmitted ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

The label expansion sought by GSK is a bid to compete with Pfizer and Moderna in the younger age groups of the RSV vaccine market. Pfizer’s Abrysvo and Moderna’s mRESVIA are both approved to prevent ...

The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...